© 2022 MJH Life Sciences and CGTLive™. All rights reserved.
© 2022 MJH Life Sciences™ and CGTLive™. All rights reserved.
October 24, 2022
The grant goes toward developing an innovative approach to gene-agnostically and autonomously regulate pressure.
September 18, 2022
Scientist have proposed several methods for converting stem cells into RPE, but there is still a gap in our knowledge of how cells respond to these stimuli over time.
September 15, 2022
Nanoscope Therapeutics’ Phase 2 STARLIGHT open-label trial enrolled 6 subjects with advanced vision loss due to a clinical or genetic diagnosis of Stargardt disease.
September 04, 2022
The therapy has demonstrated benefit in multiple models of dry AMD.
August 29, 2022
While focused on the retina, the researchers showed the platform works for the identification of AAVs that target tissues in various organs.
February 20, 2022
Researchers will use the model to study how lack of pigmentation affects RPE physiology and function.
February 15, 2022
Investigators did not find any clinical signs of rejection of the mismatched donor cells.
February 07, 2022
Applied Genetic Technologies is also developing AGTC-401 and AGTC-402 for the treatment of achromatopsia.
January 31, 2022
The clinical trial of 4D-150 expects to enroll around 60 participants with wet AMD.
January 30, 2022
Both the Sirius and Celeste phase 2/3 trials are evaluating QR-421a.